| Bioactivity | Tenuifoliside B, a component isolated from Polygalae Radix, inhibits potassium cyanide (KCN)-induced hypoxia and scopolamine-induced memory impairment. Tenuifoliside B shows potential cognitive improvement and cerebral protective effects. Tenuifoliside B has potential to become an anti-AD lead compound[1][2]. |
| Name | Tenuifoliside B |
| CAS | 139726-36-6 |
| Formula | C30H36O17 |
| Molar Mass | 668.60 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. YongjiangWu, et al. Studies on the total synthesis of tenuifoliside B. Tetrahedron. 2017 Jun. [2]. Fumito KARAKIDA, et al. Cerebral Protective and Cognition-Improving Effects of Sinapic Acid in Rodents. Biol. Pharm. Bull. 30(3) 514-519 (2007). |
Tenuifoliside B
CAS: 139726-36-6 F: C30H36O17 W: 668.60
Tenuifoliside B, a component isolated from Polygalae Radix, inhibits potassium cyanide (KCN)-induced hypoxia and scopola
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.